CM Life Sciences III Inc.
Status: Deal Closed
U=S+W/5
W=S@11.5
| IPO Proceeds, $M | $552.00M |
|---|---|
| IPO Date | Apr 7, 2021 |
| CEO | Eli D. Casdin |
| Left Lead | Jefferies |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
Healthcare
Life sciences |
| IPO Geography | Global |
| Target Company | EQRx |
| Deal Announced | Aug 6, 2021 |
| Deal Size, $M | $3,538.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings | www.sec.gov |
| Approval Vote | Dec 16, 2021 |
| Amendment Vote | TBD |
| Closing Date | Dec 17, 2021 |
Formerly CMLT
EQRX
EQRXW
| Price | 2.24 |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on CM Life Sciences III Inc.:
- Structure and cap table
- 9 directors & officers
- 19 filings and events
- 2 underwriters
- 8 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Eli D. Casdin | 47 | Chief Executive Officer and Director |
| Keith A. Meister | 47 | Chairman |
| Brian Emes | 38 | Chief Financial Officer and Secretary |
| Shaun Rodriguez | 42 | Chief Strategy Officer |
| Christian Henry | 53 | Director |
| Kwame Owusu-Kesse | 36 | Director |
| Chad Robins | 46 | Director |
| Harlan Robins | 47 | Director |
| Dr. Amy Abernethy | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Deal
Sign in to view merger details and deal financials.